Gabapentin
Product Images NDC 71717-103

9 FDA label images from Megalith Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71717-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Megalith Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66485e95 53a6 Ccc4 E053 2a91aa0a6840

66485e95 53a6 Ccc4 E053 2a91aa0a6840
Two white, oval, biconvex tablets labeled with "600" on one side and "0 E" separated by a score line on the other. The product corresponds to Gabapentin 600 mg tablets, labeled by Megalith Pharmaceuticals Inc.*
FDA Label Image

664895aa 9004 1423 E053 2a91aa0ad326

664895aa 9004 1423 E053 2a91aa0ad326
Gabapentin tablet oblong and white, with a score line on one side marked "O E" and the other side embossed with "800". The image shows two views of the tablet, front and back, without additional packaging or label information. The tablet is associated with the labeler Megalith Pharmaceuticals Inc.*
FDA Label Image

Image Description (Gabapentin 11)

Image Description (Gabapentin 11)
Chemical structure diagram showing the molecular arrangement of the active ingredient gabapentin. The diagram illustrates a cyclohexane ring bonded to amino and acetic acid functional groups.*
FDA Label Image

Image Description (Gabapentin 14 1)

Image Description (Gabapentin 14 1)
A scatter plot showing difference percentage versus daily dose in milligrams for three studies labeled a, b, and c. The x-axis represents daily dose ranging from 600 to 1,800 mg, and the y-axis shows difference percentage from 2% to 22%. Each study is indicated by distinct square markers.*
FDA Label Image

600mg/500tablets (Gabapentin B P 600 500tablets)

600mg/500tablets (Gabapentin B P 600 500tablets)
Label for Gabapentin Tablets, USP, 600 mg, film-coated tablets. The label indicates a package containing 500 tablets, distributed by Megalith Pharmaceuticals Inc. and manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. It includes storage instructions and dispensing information, with the NDC number 71717-102-50 prominently displayed.*
FDA Label Image

Image Description (Gabapentin B P 600ml 100tablets)

Image Description (Gabapentin B P 600ml 100tablets)
Label for Gabapentin Tablets, USP 600 mg by Megalith Pharmaceuticals Inc. The label indicates the package contains 100 film-coated tablets with storage instructions, dosage guidance to refer to the package insert, and a pharmacist advisory note to dispense the Medication Guide separately. It includes the NDC 71717-102-10 and manufacturer details from Shenzhen, China.*
FDA Label Image

Image Description (Gabapentin B P 800 500tablets)

Image Description (Gabapentin B P 800 500tablets)
Gabapentin Tablets USP 800 mg label showing a package of 500 tablets. Distributed by Megalith Pharmaceuticals Inc. The label includes storage instructions, dosage information, and pharmacy dispensing directions. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd, China. The label features an NDC number 71717-103-50 and a barcode.*
FDA Label Image

800mg/100tablets (Gabapentin B P 800ml 100tablets)

800mg/100tablets (Gabapentin B P 800ml 100tablets)
Label for Gabapentin Tablets USP 800 mg in a package containing 100 tablets. Distributed by Megalith Pharmaceuticals Inc and manufactured by CSPC Ouyi Pharmaceutical Co. Ltd. The label instructs storage at 25°C with permitted excursions and dispensing in child-resistant containers. The NDC code 71717-103-10 is visible.*
FDA Label Image

Image Description (Gabapentin F)

Image Description (Gabapentin F)
An equation illustrating the calculation for creatinine clearance (CLCr), which incorporates age, weight, serum creatinine, and a factor adjustment for female patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.